Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEKTAR THERAPEUTICS

(NKTR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société NEKTAR THERAPEUTICS
11/15NEKTAR THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
AQ
11/15Nektar Therapeutics Strengthens Board of Directors with Appointment of Diana M. Brainar..
PR
11/12Nektar Therapeutics Announces Data Presentations for Its Immuno-Oncology Pipeline at th..
PR
11/09Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cance..
PR
11/05NEKTAR THERAPEUTICS Management's Discussion and Analysis of Financial Condition and Re..
AQ
11/04Nektar Therapeutics Reports Third Quarter 2021 Financial Results - Form 8-K
PU
11/04NEKTAR : Q3 Earnings Snapshot
AQ
10/26Nektar to Announce Financial Results for the Third Quarter 2021 on Thursday, November 4..
PR
09/22NEKTAR THERAPEUTICS : Thinking about trading options or stock in Ambarella, Robinhood Mark..
PR
09/21NEKTAR THERAPEUTICS : Announces New Clinical Collaboration with Merck KGaA Darmstadt, Germ..
PR
09/17NEKTAR THERAPEUTICS : Corporate Presentation September 2021
PU
08/06NEKTAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/05NEKTAR : Q2 Earnings Snapshot
AQ
08/05NEKTAR THERAPEUTICS : Reports Second Quarter 2021 Financial Results
PR
07/27NEKTAR THERAPEUTICS : to Announce Financial Results for the Second Quarter 2021 on Thursda..
PR
06/15NEKTAR THERAPEUTICS : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/07NEKTAR THERAPEUTICS : to Participate in Fireside Chat at the Goldman Sachs 42nd Annual Glo..
PR
05/18NEKTAR THERAPEUTICS : Announces its First Publication of Preclinical Data Highlighting Ant..
PR
05/07NEKTAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/07NEKTAR THERAPEUTICS : Reports First Quarter 2021 Financial Results
PU
05/06NEKTAR : Q1 Earnings Snapshot
AQ
04/30NEKTAR THERAPEUTICS : Proxy Statement 14A - Apr 30, 2021
PU
04/27NEKTAR THERAPEUTICS : to Announce Financial Results for the First Quarter 2021 on Thursday..
PR
02/26NEKTAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
02/25NEKTAR : 4Q Earnings Snapshot
AQ
02/18NEKTAR THERAPEUTICS : to Announce Financial Results for the Fourth Quarter and Year-Ended ..
PR
02/17NEKTAR THERAPEUTICS : Entry into a Material Definitive Agreement (form 8-K)
AQ
01/11NEKTAR THERAPEUTICS : Results of Operations and Financial Condition, Regulation FD Disclos..
AQ
01/06NEKTAR THERAPEUTICS : ' President and CEO, Howard Robin, to Present at the 39th Annual J.P..
PR
01/05NEKTAR THERAPEUTICS : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
01/05NEKTAR THERAPEUTICS : Appoints Dr. Brian Kotzin as Interim Chief Medical Officer and Head ..
PR
2020NEKTAR THERAPEUTICS : Entry into a Material Definitive Agreement, Regulation FD Disclosure..
AQ
2020NEKTAR THERAPEUTICS : Announces Agreement with Healthcare Royalty to Sell ADYNOVATE® and M..
PR
2020NEKTAR THERAPEUTICS : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin..
AQ
2020NEKTAR THERAPEUTICS : Announces Dosing of First Patients in Phase 1/2 Study of its IL-15 A..
PR
2020NEKTAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2020NEKTAR : 3Q Earnings Snapshot
AQ
2020NEKTAR THERAPEUTICS : to Announce Financial Results for the Third Quarter 2020 on Thursday..
PR
2020NEKTAR THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
AQ
2020NEKTAR THERAPEUTICS : Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in..
PR
2020NEKTAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2020NEKTAR : 2Q Earnings Snapshot
AQ
2020NEKTAR THERAPEUTICS : to Announce Financial Results for the Second Quarter 2020 on Thursda..
PR
2020NEKTAR THERAPEUTICS : Submission of Matters to a Vote of Security Holders, Other Events (f..
AQ
2020NEKTAR THERAPEUTICS : Data Presented from Phase 1b Study of NKTR-358, a Novel T Regulatory..
PR
2020NEKTAR THERAPEUTICS : to Host Webcast Conference Call for Analysts & Investors During 2020..
PR
2020NEKTAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2020NEKTAR : 1Q Earnings Snapshot
AQ
2020NEKTAR THERAPEUTICS : Reports First Quarter 2020 Financial Results
PR
2020NEKTAR THERAPEUTICS : to Announce Financial Results for the First Quarter 2020 on Thursday..
PR
2020NEKTAR THERAPEUTICS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-..
AQ
2020NEKTAR THERAPEUTICS : to Webcast Presentation at the Cowen and Company 40th Annual Health ..
PR
2020NEKTAR : 4Q Earnings Snapshot
AQ
2020RedHill Biopharma Acquires Rights to Movantik from AstraZeneca
AQ
2020NEKTAR THERAPEUTICS : to Announce Financial Results for the Fourth Quarter and Year-Ended ..
PR
2020NEKTAR THERAPEUTICS : Announces Publication of Two Manuscripts on Lead Immuno-oncology Can..
PR
2020Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics -..
PR
2020UnitedHealth Group, BlackRock rise; Target, Nektar fall
AQ
2020NEKTAR THERAPEUTICS : Other Events (form 8-K)
AQ
2020NEKTAR THERAPEUTICS : Issues Statement Regarding FDA Advisory Committee Vote for Oxycodego..
PR
2020NEKTAR THERAPEUTICS : and Bristol-Myers Squibb Amend Strategic Collaboration Agreement for..
AQ
2020NEKTAR THERAPEUTICS : Results of Operations and Financial Condition, Other Events (form 8-..
AQ
2020Grubhub, Six Flags fall, Nektar, Infosys rise
AQ
2020SHAREHOLDER ALERT : Robbins LLP Reminds Investors Nektar Therapeutics (NKTR) Sued for Misl..
BU
2020NEKTAR THERAPEUTICS : Entry into a Material Definitive Agreement (form 8-K)
AQ
2020NEKTAR THERAPEUTICS : ' President and CEO, Howard Robin, To Present at the 38th Annual J.P..
PR
2019NEKTAR THERAPEUTICS : Change in Directors or Principal Officers, Amendments to Articles of..
AQ
2019NEKTAR THERAPEUTICS : Strengthens Board of Directors with Appointment of Myriam J. Curet, ..
PR
2019NEKTAR THERAPEUTICS : Other Events (form 8-K)
AQ
2019NEKTAR THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
AQ
2019NEKTAR THERAPEUTICS : Appoints John Northcott as Chief Commercial Officer
PR
2019NEKTAR THERAPEUTICS : Rezolute Appoints Nektar Therapeutics COO and CFO to Its Board of Di..
AQ
2019NEKTAR THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
AQ
2019NEKTAR THERAPEUTICS : to Webcast Presentation at Jefferies 2019 London Healthcare Conferen..
PR
2019NEKTAR THERAPEUTICS : Presents New Clinical and Preclinical Data from its Immuno-Oncology ..
PR
1  2Next
Upcoming event on NEKTAR THERAPEUTICS
Upcoming sector events